Some positive developments for New Brunswick pharmacists but new generic prices still causing problems

摘要

The New Brunswick government has provided pharmacists in the province with a measure of optimism about future levels of compensation, but in the short term, they continue to feel the pinch from lower generic pricing.The province announced in March that generic drug prices would decline to 40% of the brand-name price on June 1,2012, and to 35% on December 1. While Health Minister Madeleine Dube did announce a reinvestment of some of the government's savings into pharmacy services, the New Brunswick Pharmacists' Association (NBPA) said the additional revenues would not adequately offset pharmacy's losses.